We are live on ! Find out more
NM

Newtyn Management Portfolio holdings

AUM $936M
1-Year Est. Return 27.23%
This Fund
S&P 500
This Quarter Est. Return
-13.81%
1 Year Est. Return
+27.23%
3 Year Est. Return
+51.99%
5 Year Est. Return
+55.23%
10 Year Est. Return
+165.15%
AUM
$528M
AUM Growth
+$110M
Cap. Flow
+$174M
Cap. Flow %
32.89%
Top 10 Hldgs %
50.68%
Holding
87
New
48
Increased
19
Reduced
11
Closed
3

Sector Composition

Rank Sector Weight
1 Healthcare 23.3%
2 Consumer Discretionary 16.93%
3 Financials 13.63%
4 Real Estate 8.52%
5 Technology 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAR icon
1
PAR Technology
PAR
$699M
$38.2M 7.23%
1,018,068
+268,068
+36% +$9.63M
AMBP icon
2
Ardagh Metal Packaging
AMBP
$2.83B
$36.8M 6.96%
6,025,000
+3,775,000
+168% +$25.5M
AVTA
3
DELISTED
Avantax, Inc. Common Stock
AVTA
$32.3M 6.11%
1,748,389
+248,389
+17% +$4.52M
ONL
4
Orion Office REIT
ONL
$150M
$30.3M 5.73%
2,760,000
+1,210,000
+78% +$15.6M
CNNE icon
5
Cannae Holdings
CNNE
$639M
$27.1M 5.13%
+1,400,000
New +$29.4M
PPLI
6
People Inc
PPLI
$3.09B
$25.4M 4.82%
+408,365
New +$28.8M
SPB icon
7
Spectrum Brands
SPB
$2.04B
$20.5M 3.88%
249,937
MBI icon
8
MBIA
MBI
$261M
$19.5M 3.7%
1,582,811
+204,530
+15% +$2.69M
GTXAP
9
DELISTED
Garrett Motion Inc. Series A Cumulative Convertible Preferred Stock
GTXAP
$19M 3.61%
2,315,058
-234,942
-9% -$1.82M
TBPH icon
10
Theravance Biopharma
TBPH
$874M
$18.5M 3.5%
2,037,825
+662,825
+48% +$6.11M
TSVT
11
DELISTED
2seventy bio
TSVT
$17.8M 3.37%
1,346,796
-241,009
-15% -$3.28M
CIO
12
DELISTED
City Office REIT
CIO
$14.2M 2.69%
1,095,000
+192,051
+21% +$2.72M
ASTL icon
13
Algoma Steel
ASTL
$406M
$13.5M 2.55%
1,500,000
-272,704
-15% -$2.62M
PFSW
14
DELISTED
PFSweb, Inc.
PFSW
$13.3M 2.52%
1,131,505
+131,505
+13% +$1.58M
ADNT icon
15
Adient
ADNT
$1.65B
$12.5M 2.37%
421,293
-8,707
-2% -$293K
EPZM
16
DELISTED
Epizyme, Inc
EPZM
$11.1M 2.11%
+7,569,995
New +$5.56M
LW icon
17
Lamb Weston
LW
$7.22B
$10.7M 2.03%
+150,000
New +$9.91M
MACK
18
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$10.5M 1.98%
1,758,005
+44,393
+3% +$250K
LKFT
19
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.78B
$9.49M 1.8%
170,000
+56,600
+50% +$3.36M
VTOL icon
20
Bristow Group
VTOL
$1.34B
$9.33M 1.77%
398,745
+3,945
+1% +$116K
PCG icon
21
PG&E
PCG
$38.3B
$8.38M 1.59%
840,000
-460,000
-35% -$5.41M
NODK icon
22
NI Holdings
NODK
$310M
$7.23M 1.37%
440,000
AMPY icon
23
Amplify Energy
AMPY
$161M
$7.03M 1.33%
1,075,000
+50,000
+5% +$369K
LQDA icon
24
Liquidia Corp
LQDA
$7.48B
$6.84M 1.3%
+1,568,627
New +$8.1M
VRTS icon
25
Virtus Investment Partners
VRTS
$1.06B
$6.75M 1.28%
+39,500
New +$7.46M

Similar funds

Newtyn Management's Q2 2022 Portfolio in Review

As of Q2 2022, Newtyn Management held 87 positions worth $528M, up 26% from $418M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Newtyn Management deployed $174M of net new capital in Q2 2022, opening 48 new positions and adding to 19 existing holdings. Its largest new stake was Cannae Holdings: 1,400,000 shares worth $27.1M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was RLJ Lodging Trust $1.95 Series A Preferred Stock, an estimated $6.69M trimmed.

  • Newtyn Management's largest Q2 2022 buy was Cannae Holdings: 1,400,000 shares worth $27.1M.
  • Newtyn Management added most to Ardagh Metal Packaging in Q2 2022, an estimated $25.5M increase.
  • Newtyn Management's biggest Q2 2022 reduction was RLJ Lodging Trust $1.95 Series A Preferred Stock, cutting an estimated $6.69M.
  • Newtyn Management fully exited Loyalty Ventures Inc. Common Stock in Q2 2022, selling an estimated $9.48M.
  • Newtyn Management's ten largest holdings make up 51% of its $528M portfolio in Q2 2022.
  • Newtyn Management opened 48 new positions and closed 3 in Q2 2022.
  • Newtyn Management's portfolio value rose 26% quarter-over-quarter to $528M.

Based on Newtyn Management's 13F filing for Q2 2022, filed 15 Aug 2022.